Institutional Perspectives in Cancer- MM: Chaired by Amrita Krishnan, MD

Video

In Partnership With:

Institutional Perspectives in Cancer- MM: Chaired by Amrita Krishnan, MD

Institutional Perspectives in Cancer- MM: Chaired by Amrita Krishnan, MD

The live filming of this virtual event in our IPC series is now on-demand.

OncLive is proud to present the State of the Science Summits and a new virtual event, Institutional Perspectives in Cancer (IPC). Each summit and webinar will convene for a short meeting designed to educate healthcare professionals on the clinical benefits associated with new science driving new thinking in cancer management. Attendees will not only improve their knowledge of novel treatment approaches, but also leave the event the with confidence and intent to apply state-of-the-art treatment strategies to care for their patients. Each event is dedicated to the latest research in one of the following therapeutic areas: Breast Cancer, Lung Cancer, GU & Prostate Cancer, Hematology, or Melanoma.

The State of the Science Summits and IPC assemble academic and community-based physicians & healthcare professionals across key disciplines from medical and surgical oncology. Specialist experts serve as faculty for these premier and renowned oncology summits, which focus on the most relevant cancer topics to ultimately improve patient care.

Speakers

  • Maung Myo Htut, MD | City of Hope
  • Amrita Krishnan, MD | City of Hope
  • Murali Janakiram, MD | City of Hope
  • Nitya Nathwani, MD | City of Hope

Topics

  • BCMA directed therapy
  • Non-BCMA Targets & Proteasome Inhibitors in MM
  • CAR-T Cell Therapy in MM
  • HCT in MM

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
In this first episode of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, of City of Hope, Sunil Sharma, MD, of City of Hope, and Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, discuss the potential for early detection multiomic assays and the work that still needs to be done to encourage their widespread use.
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Tycel Phillips, MD
A panel of 6 experts on colorectal cancer
A panel of 6 experts on colorectal cancer
Joseph Mikhael, MD
Ariel F. Grajales-Cruz, MD, Moffitt Cancer Center
Arya Amini, MD
A panel of 6 experts on colorectal cancer
A panel of 6 experts on colorectal cancer